273 related articles for article (PubMed ID: 32856205)
1. ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.
Martínez-Rojas VA; Jiménez-Garduño AM; Michelatti D; Tosatto L; Marchioretto M; Arosio D; Basso M; Pennuto M; Musio C
J Mol Neurosci; 2021 Mar; 71(3):662-674. PubMed ID: 32856205
[TBL] [Abstract][Full Text] [Related]
2. Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA.
Jiménez Garduño AM; Juárez-Hernández LJ; Polanco MJ; Tosatto L; Michelatti D; Arosio D; Basso M; Pennuto M; Musio C
Biophys Chem; 2017 Oct; 229():68-76. PubMed ID: 28511915
[TBL] [Abstract][Full Text] [Related]
3. Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.
Martínez-Rojas VA; Arosio D; Pennuto M; Musio C
Pflugers Arch; 2021 Aug; 473(8):1213-1227. PubMed ID: 34021780
[TBL] [Abstract][Full Text] [Related]
4. New routes to therapy for spinal and bulbar muscular atrophy.
Rocchi A; Pennuto M
J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
[TBL] [Abstract][Full Text] [Related]
5. Exercise attenuates polyglutamine-mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy.
Hirunagi T; Nakatsuji H; Sahashi K; Yamamoto M; Iida M; Tohnai G; Kondo N; Yamada S; Murakami A; Noda S; Adachi H; Sobue G; Katsuno M
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):159-172. PubMed ID: 37937369
[TBL] [Abstract][Full Text] [Related]
6. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.
Gromova A; Cha B; Robinson EM; Strickland LM; Nguyen N; ElMallah MK; Cortes CJ; La Spada AR
Acta Neuropathol Commun; 2023 Jun; 11(1):90. PubMed ID: 37269008
[TBL] [Abstract][Full Text] [Related]
7. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.
Polanco MJ; Parodi S; Piol D; Stack C; Chivet M; Contestabile A; Miranda HC; Lievens PM; Espinoza S; Jochum T; Rocchi A; Grunseich C; Gainetdinov RR; Cato AC; Lieberman AP; La Spada AR; Sambataro F; Fischbeck KH; Gozes I; Pennuto M
Sci Transl Med; 2016 Dec; 8(370):370ra181. PubMed ID: 28003546
[TBL] [Abstract][Full Text] [Related]
8. Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy.
Malena A; Pennuto M; Tezze C; Querin G; D'Ascenzo C; Silani V; Cenacchi G; Scaramozza A; Romito S; Morandi L; Pegoraro E; Russell AP; Sorarù G; Vergani L
Acta Neuropathol; 2013 Jul; 126(1):109-21. PubMed ID: 23644820
[TBL] [Abstract][Full Text] [Related]
9. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
Cortes CJ; La Spada AR
Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
[TBL] [Abstract][Full Text] [Related]
11. Metabolic alterations in spinal and bulbar muscular atrophy.
Francini-Pesenti F; Vitturi N; Tresso S; Sorarù G
Rev Neurol (Paris); 2020 Dec; 176(10):780-787. PubMed ID: 32631678
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
Baniahmad A
J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy.
Gogia N; Ni L; Olmos V; Haidery F; Luttik K; Lim J
Front Mol Neurosci; 2022; 15():931301. PubMed ID: 35726299
[TBL] [Abstract][Full Text] [Related]
14. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
[TBL] [Abstract][Full Text] [Related]
15. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
Pennuto M; Basso M
J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
[TBL] [Abstract][Full Text] [Related]
17. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
Pennuto M; Gozes I
J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
[TBL] [Abstract][Full Text] [Related]
18. Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy.
Ogura Y; Sahashi K; Hirunagi T; Iida M; Miyata T; Katsuno M
Cell Death Dis; 2022 Jul; 13(7):601. PubMed ID: 35821212
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
[TBL] [Abstract][Full Text] [Related]
20. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.
Nihei Y; Ito D; Okada Y; Akamatsu W; Yagi T; Yoshizaki T; Okano H; Suzuki N
J Biol Chem; 2013 Mar; 288(12):8043-8052. PubMed ID: 23364790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
